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Abstract
Background: Low and middle-income countries like India with a large youth population experience a different
environment from that of high-income countries. The Consortium on Vulnerability to Externalizing Disorders and
Addictions (cVEDA), based in India, aims to examine environmental influences on genomic variations,
neurodevelopmental trajectories and vulnerability to psychopathology, with a focus on externalizing disorders.
Methods: cVEDA is a longitudinal cohort study, with planned missingness design for yearly follow-up. Participants
have been recruited from multi-site tertiary care mental health settings, local communities, schools and colleges. 10,
000 individuals between 6 and 23 years of age, of all genders, representing five geographically, ethnically, and
socio-culturally distinct regions in India, and exposures to variations in early life adversity (psychosocial, nutritional,
toxic exposures, slum-habitats, socio-political conflicts, urban/rural living, mental illness in the family) have been
assessed using age-appropriate instruments to capture socio-demographic information, temperament,
environmental exposures, parenting, psychiatric morbidity, and neuropsychological functioning. Blood/saliva and
urine samples have been collected for genetic, epigenetic and toxicological (heavy metals, volatile organic
compounds) studies. Structural (T1, T2, DTI) and functional (resting state fMRI) MRI brain scans have been performed
on approximately 15% of the individuals. All data and biological samples are maintained in a databank and
biobank, respectively.
Discussion: The cVEDA has established the largest neurodevelopmental database in India, comparable to global
datasets, with detailed environmental characterization. This should permit identification of environmental and
genetic vulnerabilities to psychopathology within a developmental framework. Neuroimaging and
neuropsychological data from this study are already yielding insights on brain growth and maturation patterns.
Keywords: Externalizing disorders, Study protocol, Vulnerabilities, Longitudinal study, Cohort, Environmental
exposures
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Background
India is home to the world’s largest number of adoles-
cents and young people (10–24 years old), comprising
about a third (>400 million) of its population [1]. Nearly
20% of young people experience a mental health condi-
tion, bearing a disproportionately high burden of mental
morbidity [2–4]. The Consortium on Vulnerability to
Externalizing Disorders and Addictions (cVEDA) is a
multi-site, international, collaborative, cohort study in
India, setup to examine the interactions of environmen-
tal exposures, and genomic influences on neurodevelop-
mental trajectories and downstream vulnerability to
psychopathology, with a specific focus on externalizing
spectrum disorders. cVEDA spans seven recruitment
centres, representing different geographical, physical and
socio-cultural environments, across India. This paper
presents the background, rationale and protocol of the
cVEDA study.
The need for longitudinal studies using dimensional,
multi-modal measures to study the etiopathological basis
of psychiatric morbidity
Birth-cohort studies show that >70% psychiatric illnesses in
adults begin before the age of 18 years [5]. Temperamental
and psychological disturbances during childhood are prom-
inent predictors of psychiatric disorders in adult life [6].
Childhood onset psychiatric disorders often extend into
adulthood on a homotypic or heterotypic continuum [7].
Psychiatric morbidity is increasingly believed to be predi-
cated upon a shared genetic and neurodevelopmental con-
tinuum, suggested by commonalities in clinical phenotype,
neuroimaging characteristics, neuropsychological impair-
ments, and environmental risk factors [8, 9]. Different psy-
chiatric disorders rather than being discrete categories,
possibly reflect differences in timing, severity and patterns
of genetic expression and neurodevelopmental deviations
[10]. Longitudinal studies over the developmental lifespan
are ideally suited to study origins of psychiatric morbidity
by tracking developmental trajectories, identifying devia-
tions, and studying how deviations, and their interactions
with genes and environment, relate to psychopathology
[11–13]. Additionally, a combination of neuroimaging,
neuropsychological, toxicological, and psychometric modal-
ities better facilitates construction of models with high pre-
dictive power [14].
Role of the ‘exposome’ in determining psychiatric
morbidity and the need to study it in low and middle-
income countries
Psychiatric disorders have complex, multi-factorial,
poly-gene-environmental etiologies [15]. Gene x envir-
onment correlation (rGE) and interaction (GxE) are
two broad mechanisms that underlie this complex
interface [16]. The exposome [17] includes general
external environment (socio-economic, habitat), spe-
cific external environment (pollutants, infectious
agents, substance use) and internal environment
(physical activity, oxidative stress, etc.) [18]. Table 1
depicts the time-dependent impact of environmental
exposures on developmental and psychopathological
outcomes [19, 20].
The exposome, which can potentially modify genetic
expression, is multi-cultural. Extrapolating findings
from high-income settings to low and middle-income
countries (LMIC) is problematic [47]. Ethnic back-
grounds, in a diverse country like India [48], and the
prevalence of exposures and outcomes pertinent to
development and health vary by income group and
geography [49–51]. Certain environmental risk factors
(nutritional stress, environmental neurotoxins and cul-
turally dependent forms of psychosocial stress) are
largely specific to developing societies. Maternal mal-
nutrition, suboptimal breast-feeding, childhood malnu-
trition, unsafe water, poor sanitation, indoor smoke,
and high-risk behaviors are leading causes of death
and disability-adjusted life years in LMIC [52, 53]. It
is necessary to study the exposome, in diverse set-
tings, transactionally and longitudinally, with attention
to both distal and proximal influences [54] to under-
stand its role in psychopathology/resilience [55]. Set-
ting up longitudinal studies in LMIC, using measures
comparable to existing studies can provide a more
nuanced understanding of the gene-environment con-
tributions to psychiatric morbidity.
The focus on externalizing disorders
Externalizing disorders are the third most prevalent class
of mental disorders (after anxiety and depression) [56].
These include attention-deficit/hyperactivity disorder
(ADHD), Oppositional defiant disorder (ODD), Conduct
disorder (CD) in childhood, and adult ADHD, mood dis-
orders, substance use disorders, impulse control disor-
ders, emotionally-unstable personality disorder, and
antisocial personality disorder in adulthood. They are as-
sociated with significant impairment, and health and
non-health sector costs [57, 58]. A dimensional frame-
work of “externalizing psychopathology” encompasses
poor impulse control, poor attention allocation, height-
ened emotional reactivity, verbal and physical aggression,
violation of rules, and substance abuse [59]. Individuals
at ‘high risk’ for externalizing disorders have different
patterns of brain activity, neuroadaptation, cognition,
and externalizing temperamental traits [60–66]. A num-
ber of studies have documented variations in brain re-
gional volumes [67], regional white matter integrity [68],
functional blood flow characteristics [69, 70], social
intelligence and corresponding functional brain activa-
tions [71], brain activation patterns during response
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inhibition tasks [72], differences in neurophysiological
parameters like P300 and pre-exposure cognitive deficits
[62]. Interestingly, network disruptions are incrementally
related to externalizing symptoms and are proportional
to the alcoholism family density [73]. These variations
are also seen as intermediate phenotypes in individuals
with externalizing disorders [74–76], suggesting that
maturation delays, deficits and deviations predate dis-
order onset and hold promise as early identification
markers of vulnerability. Preliminary investigations have
also shown that young adults at ‘high risk’ could ‘catch-
up’ on brain maturational differences, emphasizing the
role of early interventions [77, 78]. The externalizing
spectrum has complex, multi-factorial underpinnings
(Fig. 1), strong links with sequential development of
various disorders and plausibly a common inherited
causality [5]. This makes them particularly interesting in
the search for common genetic and neurodevelopmental
vulnerabilities and moderating environmental influences.
Key concepts emerging from research on the etio-
pathological basis of psychiatric morbidity have
highlighted – a genetic and neurodevelopmental con-
tinuum, a poly-gene-environmental etiopathogenesis,
unique socio-cultural contexts as environmental determi-
nants of psychopathology, variations in brain trajectories
leading to different psychopathological outcomes, and the
differential impacts of environmental stressors on devel-
opmental trajectories over various life-stages. It follows
that studying disparate environmental influences, across
the developmental lifespan, on genetically determined
trajectories of multimodal brain endophenotypes, using
dimensional, multi-modal measures in a longitudinal
Table 1 Developmental and psychopathological impact of environmental exposures over different life stages
Life stage Exposure Developmental impact Impact on mental morbidity
Fetus Maternal mal-nutrition Early brain development, including
key serotonergic and dopaminergic
signalling systems
Externalizing problems in early
childhood [21]
Intra-uterine growth retardation/Low birth weight Developmental programming
of physiological systems
Wide range of cognitive, emotional
and behavioural outcomes [22]
Maternal substance use Later growth and development
including trans-generational effects [23]
Wide range of cognitive, emotional
and behavioural outcomes
Psychosocial stress during pregnancy/ maternal
depression & anxiety
Behavioural disturbances in later
childhood [24]
Environmental pollutants – toluene in traffic smoke,
organophosphates in pesticides
Developmental neurotoxicity;
Neuroimaging evidence of structural
abnormalities
Cognitive deficits [25, 26]
Early
childhood
Pollutants, environmental toxins – polycyclic aromatic
hydrocarbons in biomass fuels, tobacco smoke,
arsenic in ground water, fluoride, lead,
polychlorinated biphenyls from insulators in electrical
equipment, phthalates from plastics and cosmetics
Injury to the developing human brain
either through direct toxicity or
interactions with the genome [27]
Low verbal IQ [29]; Cognitive deficits
among preschool-age children [30];
behavioral abnormalities [31]
Neurotoxicity with effects persistent
throughout life [28]
Absence of primary attachment figure/poor
parenting
Deficits in cognitive and socio-
emotional development [32]
Indiscriminate friendliness, poor peer
relationships [33]
Under-nutrition Synaptic pruning, Myelination,
Executive functioning [34, 35]
Risk of emotional and behavioural
problems [36]; High prevalence of
health-harming behaviours [37]
Childhood &
adolescence
Poverty/deprived neighbourhoods Via parental psychopathology, less
positive parenting, neglect, poor
monitoring [38]
Higher prevalence of SUDs [39];
various negative behavioural
outcomes [40]; Conduct problems [41]
Exposure to war and conflict Range of psychopathology, including
post-traumatic stress disorder [42]
High conflict home environment (parental marital
conflict, parental divorce)
Disruptive behaviours [43]
Harsh parenting, physical abuse Disruptive and emotional
psychopathology [44]
Deviant peer relationships Behavioural reinforcement, exchange
of techniques
Delinquentbehaviours [45]
Adolescence Substance use Interferes with brain maturation
especially in areas affecting self-
regulation and control
Substance use disorders and global
difficulties in adult functioning [46]
Sharma et al. BMC Psychiatry            (2020) 20:2 Page 3 of 14
framework could uncover key etiopathological processes
underlying psychiatric morbidity.
The cVEDA collaboration
The c-VEDA is a collaborative venture between re-
searchers from India and the United Kingdom (UK), set
up under a joint initiative on the aetiology and life-
course of substance misuse and its relationship with
mental illness, by the Medical Research Council, UK
(MRC) and the Indian Council for Medical Research
(ICMR). National Institute of Mental Health and Neuro-
sciences, Bangalore (NIMHANS) and King’s College
London (KCL) are the coordinating centres in India and
the UK, respectively. Other participating centres from
India include – (i) Post Graduate Institute of Medical
Education and Research, Chandigarh (PGIMER), (ii)
ICMR-Regional Occupational Health Centre (ROHC),
Kolkata, (iii) Regional Institute of Medical Sciences, Im-
phal (RIMS), (iv) Holdsworth Memorial Hospital, My-
sore (HMH), (v) Rishi Valley Rural Health Centre,
Chittoor (RV), and vi) St. John’s Research Institute,
Bangalore (SJRI). European collaborators include re-
searchers who are part of major longitudinal imaging
genetics studies – “Reinforcement-related behaviour in
normal development and psychopathology” (IMAGEN)
(https://imagen-europe.com), the “Avon Longitudinal
Study of Parents and Children” (ALSPAC) (http://www.
bristol.ac.uk/alspac/), and the “Study of Cognition, Ado-
lescents and Mobile Phones” (SCAMP) (https://www.
scampstudy.org).
Objectives of the cVEDA study
The cVEDA study is designed to (a) establish a cohort of
about 10,000 individuals within specified age bands – 6–
11, 12–17, 18–23 years; (b) Conduct detailed phenotypic
characterization, with special emphasis on externalizing
behaviors (temperament and disorders), in the cohort
and parents of all participants; (c) Assess environmen-
tal exposures (psychosocial stressors, societal discrim-
ination, nutrition and asset security, environmental
toxins) thought to impact gene expression, brain de-
velopment, temperaments and behaviors; (d) Establish
a sustained and accessible data platform and a bio-
resource with an integrated database to facilitate ana-
lyses and collaborations; and (e) Build research cap-
acity by joint UK–India initiatives.
Methods/Design
Study design
The cVEDA is a cohort of individuals aged 6–23 years
across 7 Indian sites. It draws upon existing research
systems with well-established tracking and follow-up
mechanisms, previously employed in studying the im-
pacts of varied risk factors on non-communicable dis-
eases [82–85]. Cohorts recruited at each centre are
followed-up 1 and 2 years after baseline assessments.
The study employs a planned missingness [86] (Fig. 2)
approach in which participants are randomised to
follow-up either 1 or 2 years after enrolment. Such a de-
sign permits three waves of data collection to be
achieved while reducing the cost of measurement per
wave. Since participants are randomly assigned to be
present/missing at each follow-up, missing data are com-
pletely at random and hence parameters of interest can
be estimated without bias. In addition, loss-to-follow up
can be reduced as participants suffer less with study-
fatigue and also fieldworkers can target their limited re-
sources more effectively when encouraging participants
to return.
Since the primary interest of the study is in tracking
development over almost the entire developmental life-
span there are cost/time benefits due to recruiting
across a wide range of participant ages. Age-variability
within-wave permits an accelerated cohort design [87]
to be employed (Fig. 2). Here a given age-range can be
spanned in a shorter period of time by considering the
cohort as being comprised of multiple sub-cohorts each
of a different age at recruitment. A variety of longitu-
dinal statistical models, either within a Structural Equa-
tion Modelling or Multilevel Modelling framework,
including latent growth models (aka mixed-effects
models) can take full advantage of such data. For ex-
ample, using at joint model one might examine the lon-
gitudinal interplay between alcohol use and antisocial
behaviour through adolescence. In addition, these
models, through their use of a maximum-likelihood
Fig. 1 Complex, multi-factorial underpinnings of externalizing disorders [60–66, 79–81]
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approach to missing data, based on a Missing At Ran-
dom assumption, can demonstrate a high level of statis-
tical power for a fraction of the monetary and time
costs of following all individuals for the whole time
period. Such an analytical framework is also compatible
with the planned-missingness aspect to the study de-
sign described above.
Timeline
The cVEDA study started in February 2016. After
9 months spent in study set up (staff recruitment, trans-
lations of study instruments into 7 Indian regional lan-
guages, setting up digital data capture platform, training
of recruitment and assessment teams, and quality con-
trol exercises), recruitment started in October 2016. Re-
cruitment, baseline assessments and randomized follow-
up have been continued in parallel. Under the current
funding cycle, we have completed recruitment and base-
line assessments; and 1 and 2 year follow-ups on a part
of the sample (Fig. 3).
Sample
Baseline Clinical Assessment: The cVEDA had a target
baseline sample size of approximately 10,000 participants
in three age bands: C1 (6–11 years), C2 (12–17 years) and
C3 (18–23 years). As the objectives of the study were to
carry out detailed phenotypic characterisation of partici-
pants, examine their environmental exposures and gene-
environment interactions that may modulate brain devel-
opment and affect externalizing and addictive behaviour
patterns, the study sample needed to be as large as feasibly
possible whilst being representative of the geographic, so-
cioeconomic and cultural diversity of India. The target
sample sizes at each recruitment site were decided based
Fig. 2 Accelerated longitudinal with planned missingness design and the generation of developmental trajectories (latent growth model)
Fig. 3 cVEDA study timeline
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upon each site’s estimated capacity to recruit individuals
over a 3-year recruitment period, given the site lead’s un-
derstanding about ground realities and experience from
past studies. The sample represents five geographically,
ethnically, and socio-culturally distinct regions; varied
environmental risks: toxic exposures (coal-mines),
slum-dwellers, socio-political conflict zones (insur-
gency and inter-ethnic violence); urban and rural
areas; school and college attendees; and familial high
risk (children of parents with substance use or other
mental disorders), in order to have an adequate repre-
sentation of individuals likely to convert to externaliz-
ing disorders.
The study followed non-probabilistic convenience sam-
pling based on accessibility to potential participants in
local schools, colleges, community and clinics. Exclusion
criteria included legal blindness/deafness, seizure disorder
active in the last 1 month, severe physical or active mental
illness, refusal of consent, or inability to participate in
follow-up assessments (e.g. due to migration). Individuals
with specific contra-indications (metal implants, electrical
devices, severe claustrophobia) were excluded from neuro-
imaging. Site-wise exposure characteristics and baseline
sample sizes are depicted in Fig. 4. Whilst the recruitment
approach was pragmatic, this type of sampling technique
may not allow for results that can be generalised to the
entire population. However, given the scope and breadth
of exposures being assessed, this approach is useful for the
target research objectives and may help generate new hy-
potheses for future studies [88].
Biological samples and neuroimaging: Blood/buccal
swab and urine samples were collected from participants
at baseline. Around 15% of the baseline sample, i.e. con-
senting participants, underwent neuroimaging. Even at
the risk of biased sampling, this strategy was adopted
given the wide age range, high rate of refusal, especially
in non-clinical populations, and the unavailability of re-
search MRI scanners in 4 out of 7 sites.
Procedure
a) Phenotypic characterization
Assessments involved dimensional and categorical pheno-
typic characterization. The questionnaires and assessment
protocols were translated (and back-translated using
standard WHO protocols) from English into seven Indian
languages (Hindi, Kannada, Telugu, Tamil, Manipuri,
Bengali, Punjabi) for use across seven recruitment sites.
Age-appropriate instruments are used to capture socio-
demographic information, temperament, environmental
exposures, parenting, psychiatric morbidity, and neuro-
psychological functioning. Table 2 details the domains of
assessments, tools and protocols.
Neuroimaging
Resting state fMRI (rsfMRI), Diffusion MRI (dMRI) and
Structural MRI (sMRI) scans are done at baseline, and are
being done for the randomized consenting participants at
follow-up. Structural and rsfMRI are collected on 3 T scan-
ners (Siemens, Germany; Philips, The Netherlands). To en-
sure comparability of image-acquisition techniques and
‘pool’ability of the multi-site MRI data, a set of parameters,
particularly those directly affecting image contrast or
signal-to-noise are held constant across sites (https://cveda.
org/standard-operating-procedures/) (Table 2).
Blood/saliva samples for genetic studies
Blood samples (at least 10 ml, EDTA and Tempus tubes)
are collected at baseline for DNA, RNA and plasma lead
Fig. 4 cVEDA sample distribution and recruitment site characteristics(Map of India source: http://mapsopensource.com/india-states-outline-map-
black-and-white.html; As stated on the webpage “All the content by www.mapsopensource.com is licensed under a Creative Commons
Attribution 3.0 Unported License”)
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Table 2 cVEDA sample characterisation: Assessment domains, tools& protocols
Assessment domain Questionnaires 6–11 years 12–17 years 18–23 years Follow-up
Socio-demographic
information
Socio-demographic questionnaire [89] ✓ ✓ ✓ ✓
Migration questionnaire [90] ✓ ✓ ✓ ✓
Exposures questionnaires Environmental exposures questionnaire [91] ✓ ✓ ✓ ✓
Adverse childhoodexperiences – International questionnaire [37] ✓ ✓ ✓
Children’s Revised Impact of Event Scale [92]
Short food questionnaire (modified Food Frequency Questionnaire) [93] ✓ ✓ ✓
Pregnancy History Instrument – Revised [94] ✓ ✓ ✓
Indian Family Violence and Control Scale [95] ✓ ✓ ✓
Mobile use questionnaire (Self-report) [96] ✓ ✓
Mobile use questionnaire (Parent-report) –from the SCAMP study
(https://www.scampstudy.org)
✓
Life Events Questionnaire [97] ✓
Questions on urbanicity (devised to explore all places a participant
has successively resided at)
✓ ✓ ✓
Parenting Alabama parenting questionnaire – Child & Parent [98, 99] ✓ ✓
Adolescent attachment questionnaire [100] ✓
Parental bonding instrument [101] ✓
Temperament Childhoodbehavior questionnaire [102] ✓
Early adolescent temperament questionnaire [103] ✓
Adult temperament questionnaire [104] ✓
Big Five Personality inventory [105] ✓
Strengths & difficulties questionnaire – Parent [106] ✓ ✓ ✓
Strengths & difficulties questionnaire – Child [107] ✓ ✓
Strengths & difficulties questionnaire – Self-report [107] ✓ ✓
Psychiatric morbidity MINI-KID [108] ✓ ✓ ✓
MINI-5 [109] ✓ ✓
ASSIST-Plus [110–113] ✓ ✓ ✓ ✓
ASRS – ADHD [114] ✓
Family history Family history questionnaire (clinical assessment for presence of
medical and/or psychiatric disorders in first-degree relatives of
the participant)
✓ ✓ ✓
Medical history Medical problems questionnaire (clinical assessment for presence
of medical disorders in the participant)
✓ ✓ ✓
Puberty PubertalDevelopmentScale [115] ✓ ✓
Neuropsychological
assessment
Psychology Experiment Building Language (PEBL)[96] ✓ ✓ ✓ ✓
Digit span test – forward and reverse
Corsi block test – forward and reverse
Now or later test
Trail making test
Sort the cards
Stop signal task [122]
Balloon analogue risk task [121]
Emotion recognition task
Social Cognition Rating Tool in the Indian Setting [116]
Anthropometry Height ✓ ✓ ✓ ✓
Weight
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estimation, as per a Standard Operating Protocol
(https://cveda.org/standard-operating-procedures/).
Plasma, ‘buffy coat’ (white blood cells) and red blood
cells, from centrifugation of blood samples in EDTA
tubes, are transferred into labeled aliquots for storage at
a central biobank. Tempus tubes and blood component
aliquots are stored at − 80 °C. Samples are kept frozen at
all times including during transport using temperature-
controlled logistics. For participants who do not consent
for a blood sample, or where it isn’t possible to obtain a
blood sample (e.g. failure to identify a suitable vein for
blood draw or an insufficient amount of blood sample),
a buccal swab (for DNA) is taken.
Plasma and urine samples for toxicological studies
Estimation of lead in plasma, and arsenic, metabolites of to-
bacco (cotinine) and volatile organic compounds (VOCs),
in urine samples, is incorporated in cVEDA as a measure of
exposure to environmental neurotoxins. An aliquot of
plasma isolated from blood samples is used for lead estima-
tion. Lead is estimated in plasma as evidence suggest that
plasma lead represents the toxicologically labile fraction of
lead freely available to interact with target tissue rather than
lead in whole blood [117, 118]. Mid-stream urine samples
collected in sterilized and capped polythene bottles, and
stored in deep freezers at −20 °C till analysis. Urine samples
are analysed for total arsenic and metabolites of VOCs in-
clude trans, trans-muconic acid and s-phenyl mercapturic
acid (benzene metabolites), hippuric acid (toluene metabol-
ite), mandelic acid (ethylbenzene metabolite) and methyl-
hippuric acid (xylene metabolite). Analytical methods for
toxicological analysis are presented in Table 2. To validate
the toxicological assessments in participants, environmental
assessments of VOCs in ambient air and arsenic in water
will also be carried out. In a phased manner, exposure to
other critical developmental neurotoxins, like pesticides,
phthalates and polychlorinated biphenyls, will also be
assessed.
Follow-up assessments
At follow-up, assessments relevant to tracking development,
changes in environmental exposures, and psychopathology
Table 2 cVEDA sample characterisation: Assessment domains, tools& protocols (Continued)
Assessment domain Questionnaires 6–11 years 12–17 years 18–23 years Follow-up
Mid arm circumference
Leg length
Head circumference
Neuroimaging Structural MRI ✓ ✓ ✓ ✓
T1-weighted, 3D magnetization prepared gradient echo
sequence (MPRAGE) based on the ADNI protocol
(http://www.loni.ucla.edu/ADNI/Cores/index.shtml):
T2 weighted fast- (turbo-) spin echo
FLAIR scans
Diffusion MRI
Single-shot spin-echo EPI sequence
Single acquisition session
Acquisition repeated with reversed blips
Resting state functional MRI
BOLD functional images acquired with a gradient-
echoplanar imaging (EPI) sequence, using a relatively
short echo-time to optimize reliable imaging of
subcortical areas.
Toxicology Urinary volatile organic compounds ✓ ✓ ✓
Solid phase extraction followed by High Performance
Liquid Chromatography.
Urinary Arsenic
Flow injection system by Atomic
Absorption Spectrometer (PerkinElmer AA800, USA)
Plasma lead
Transversely-heated graphite furnace and Zeeman
background correctionusing Graphite Furnace
Atomic Absorption Spectrometer
(PerkinElmer AA800, USA)
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are done. These include – socio-demographic and migration
information, environmental exposures, MINI/MINI-KID,
Strengths and Difficulties Questionnaire, ASSIST-Plus, and
neuroimaging. MRI scans are repeated for those participants
who underwent neuroimaging at baseline and consented for
a repeat scan in follow-up. These would help track struc-
tural and functional brain growth trajectories. Blood/buccal
swab samples are also collected from all consenting partici-
pants in follow-up, for epigenetic investigations.
Data analysis
Handling missing data
Attrition, difficulties in assessment within a set follow-
up time frame, changes in recruitment techniques (face-
to-face interviews to telephonic-based assessments),
changes in reporting individuals (mother to child or vice
versa), and, changes in questionnaire design are chal-
lenges in longitudinal cohorts. In cVEDA, we also have
missing data from exogenous factors such as economic
migration, weather catastrophes and political instability
resulting in displacement of participants from one geo-
graphical area to another. These would be significant ca-
veats to fitting longitudinal growth models for behaviour
problems. “Planned missingness” improves the efficiency
of longitudinal studies without compromising validity.
As this missingness is by design we are able to assume
that data are ‘missing completely at random’ and hence
likelihood-based methods would produce unbiased effect
estimates. Planned missingness can also affect the level
of unplanned missingness. By reducing the number of
waves of data that each participant contributes,
participant-fatigue is reduced, study-dropouts are lower
and, thereby, the rates of unplanned missingness.
Statistical analysis and modelling
The cVEDA will have first and foremost a descriptive
analysis, as it is the first neurodevelopmental study of
its kind in India with a diverse socioeconomic, geo-
graphic and cultural spread. It will present findings
on key externalizing traits across the cohort with
cluster analysis conducted per site to determine ef-
fects attributable to site variations. The results of
cVEDA will be informed by and compared with the
findings of European cohorts of children and young
adults such as IMAGEN, ALSPAC, and SCAMP for
behavioural traits (temperament and disorders), envir-
onmental exposures (e.g. psychosocial stressors and
environmental toxins) and gene-environment interac-
tions. Further, techniques like structural equation
models [119] that estimate and converge multiple
pieces of the outcome into a single latent growth or
specific latent classes by age will be used to identify
vulnerability factors for externalizing disorders and
other mental health outcomes.
Establishment of a repository data and biobank
All cVEDA assessments are run on a digital platform
using Psytools software (Delosis Ltd., UK). Data is first
synchronized with the Psytools server, from where it is
accessed by data management teams in India, UK and
France. The final data storage server (Dell power edge
R530 Rack server) is located at NIMHANS, along with a
back-up safety system and a mirror data storage system
in France. The data management team conducts sanity
checks and feedback is regularly sent to recruitment
sites.
Biological samples form part of a biobank located at
NIMHANS. The databank and the biobank are a re-
source to facilitate research by consortium partners as
well as collaborators investigating other areas of mental
health, its interface with physical health, and cross-
cultural comparisons.
Quality control
Quality control measures have been incorporated in the
study protocol right from the beginning. Interviewer
training, on-site and online, followed by mock interview
assessments and feedback was conducted in the prepara-
tory phase of the study. Following start of study on the
field, India and UK based study coordinators conduct
weekly recruitment meetings during which recruitment
progress and completeness of data entry are reviewed.
Standard operating procedures (SOPs) ensure
consistency in biological samples collection and neuro-
imaging. Additionally, quality control procedures for
neuroimaging are implemented at each site: (i) a phan-
tom [120] is scanned to provide information about geo-
metric distortions and signal uniformity related to
hardware differences in radiofrequency coils and gradi-
ent systems, (ii) healthy volunteers are regularly scanned
at each site to assess factors that cannot be measured
using phantoms alone, and iii) after every subject scan, a
quick 2-min script (https://github.com/cveda/cveda_mri)
is run at the acquisition centre to detect any subject
−/scanner-related artifacts and a decision is made if the
data needs to be re-acquired. The India-based study co-
ordinator also regular conducts site visits to monitor ad-
herence to the study protocol.
Discussion
This paper presents the background and protocol of the
cVEDA study. The study is designed to answer questions
about the developmental, genomic, and environmental
underpinnings of psychopathology. This has implications
for preventive and early interventions for mental disor-
ders. Biological samples collected from all participants
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significantly enrich exposome characterization in the
sample and this will aid in discovering biomarkers of ex-
posure and early disease through omic technologies (epi-
genomics, adductomics, proteomics, transcriptomics and
metabolomics). Whilst it is beyond the scope of the
current funding to carry out extensive omic analyses, we
are establishing an integrated exposome database and
biobank to facilitate future analyses. The cVEDA cohort
is a substantial addition to, and provides comparative
and cross-cultural datasets for international studies –
IMAGEN that looks at biological and environmental fac-
tors affecting reinforcement related behaviours in teen-
agers; SCAMP looking at effects of mobile phone use on
cognition in adolescents; ALSPAC with several decades
of longitudinal data on developmental, environmental
and genetic factors affecting a person’s overall health
and development.
Our initial analyses have focused on establishing
trajectories (behavioural, temperamental, neuropsycho-
logical) to increase our understanding of maturational
brain changes and permit in-depth enquiries into the
relationships between brain networks, cognition, be-
havior and environment during development, and
how these contribute to the genesis of neurodevelop-
mental disorders.
Genomic DNA isolated from the buffy coat compo-
nent of blood will be used for genetic studies, using next
generation genotyping methods as well as genome wide
epigenetic studies. RNA from samples stored in Tempus
tubes will be used for transcriptome studies by arrays or
RNA sequencing methods. Using statistical data reduc-
tion techniques (e.g: principal components analysis),
endophenotype-genetics relationships (e.g: parallel inde-
pendent component analysis), and quantitative trait loci,
we will examine genetic basis of neuroimaging and
neuropsychological endophenotypes.
Community engagement and capacity building
In addition to being a research initiative, cVEDA is an
opportunity for community engagement. At the comple-
tion of the study we will provide a summary note to par-
ticipants and an opportunity for group discussion of
results, implications and treatment options, where rele-
vant. The cVEDA consortium facilitates exchange of re-
search, technical and statistical expertise and support
with dissemination and publication of research findings
via workshops and training programmes organised an-
nually at the cVEDA investigators’ meetings at various
study sites in India.
cVEDA is a first of its magnitude research exercise in
India, an opportunity for research growth and capacity
building. The establishment of a completely digitized
data collection and transfer platform minimizes human
error greatly. It also makes a large databank rapidly
available to researchers working in the field. Through
collaboration with institutions in the UK, research
scholars also have the opportunity to partner with inter-
national researchers and faculty to build their research
repertoire.
In conclusion, the cVEDA has established the lar-
gest neurodevelopmental database in India. The iden-
tification of environmental risk factors that contribute
to vulnerabilities for psychiatric morbidity could have
huge implications in public health interventions and
prevention of psychiatric morbidity, in India. This
unique database will facilitate international research
collaborations, to study cross-cultural variations in
the determinants of psychopathology.
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